Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial
Titel:
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial
Auteur:
Haidar, Ghady Thomas, Steven Loubet, Paul Baker, Ross I Benfield, Thomas Boonyaratanakornkit, Jim Kiertiburanakul, Sasisopin Kim, Alfred H J Longbrake, Erin E Molina, Jean-Michel Paredes, Roger Tucker, David Uriel, Alison Weinmann-Menke, Julia Aksyuk, Anastasia A Clegg, Lindsay E Currie, Alexander Yang, Haitao Flyrin, Karin Gibbs, Michael Shroff, Manish Perez, John L Chang, Lee-Jah Cohen, Taylor S